Skip Navigation

Nephrology Dialysis Transplantation 2005 20(Supplement 2):ii48-ii53; doi:10.1093/ndt/gfh1082
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Berney, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berney, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oupjournals.org

Impact of HLA matching on the outcome of simultaneous pancreas–kidney transplantation

Thierry Berney1, Jacques Malaise2, Philippe Morel1, Christian Toso1, Sandrine Demuylder-Mischler1, Pietro Majno1, Léo H. Bühler1, Gilles Mentha1 and the Euro-SPK Study Group

1 Divisions of Visceral and Transplantation Surgery, Geneva University Hospitals, Geneva, Switzerland and 2 Department of Kidney and Pancreas Transplantation and Organ Procurement, Cliniques Universitaires St Luc, Université Catholique de Louvain, Brussels, Belgium

Correspondence and offprint requests to: Dr Jacques Malaise, Department of Kidney and Pancreas Transplantation and Organ Procurement, Cliniques Universitaires St Luc, Université Catholique de Louvain, Avenue Hippocrate, 10/2207, B-1200 Brussels, Belgium. Email: jacques.malaise{at}chir.ucl.ac.be

Background. Simultaneous pancreas–kidney (SPK) transplantation has become the therapy of choice for type 1 diabetic patients with end-stage renal disease. The current analysis examined the impact of human leukocyte antigen (HLA) matching on graft outcome following SPK transplantation. The study population was obtained from patients enrolled in the Euro-SPK 001 study.

Methods. The effect of HLA matching on graft function and survival was assessed in 180 SPK recipients in whom complete donor–recipient HLA data were available. A group of 45 patients with 0–3 HLA mismatches (MM) was compared with a group of 135 patients with 4–6 MM.

Results. There were no differences in 3-year kidney, pancreas or patient survival between the 0–3 and 4–6 MM groups. Biological parameters of kidney and pancreas graft function were similar in both groups. Significantly more patients with 0–3 MM (66%) were rejection-free at 3 years than was the case among those with 4–6 MM (41%; P = 0.003). The relative risk of acute rejection was 2.6 times higher among patients with 4–6 MM than among those with 0–3 MM.

Conclusions. There was no evidence that HLA matching was associated with improved kidney or pancreas survival. However, a higher rate of acute rejection was observed with poor HLA match, which may impact long-term survival.

Keywords: graft survival; HLA matching; kidney–pancreas transplantation; multicentre study; prospective study; rejection


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.